Amarin Corp Plc (AMRN)

[ggwpq]

"If the FDA confirms the drug’s effectiveness, a “fair” price for tirzepatide could be around $13,000 annually, or around $1,100 a month, said Dr. David Rind, the chief medical officer for the Institute for Clinical and Economic Review, a research group that helps determine fair prices for drugs."

I don't understand: insurance companies said it's expensive to cover Vascepa which cost less than $5000 a year but could reduce CVD by 25%.

https://www.nbcnews.com/health/health-news/weight-loss-drug-affordability-rcna60422